Business
The pandemic drove the unprecedented funding surge as the healthcare industry swiftly innovated and adopted virtual and hybrid care models.
Polish-based Docplanner steps up expansion plans in Germany.
The firm plans to further develop its blood typing technology.
The regulation will enable joint clinical assessments between EU member states.
The Series C brings its total raise to $160 million.
Funding will help take its DTx solutions through regulatory approvals and to market in the UK and US.
Global healthtech has received $51.3 billion in investment this year, marking new highs for venture capitalist interest in the sector and identifying London as the fastest growing healthtech hub globally.
Also: RenalSense scores $14 million for its renal diagnostic, and InsurMedix rakes in $15 million for fertility insurance.
The resignation comes a week after the company announced its cofounders were leaving their roles.
SWORD raised $163 million in Series D funding, which allowed for a secondary round where it scooped up another $26 million.